|
|
|
Volumn 19, Issue 2, 2004, Pages 1-
|
|
Special report: cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
CONGESTIVE HEART FAILURE;
COST BENEFIT ANALYSIS;
ECONOMICS;
EVIDENCE BASED MEDICINE;
FOOD AND DRUG ADMINISTRATION;
HEALTH INSURANCE;
HEART ASSIST DEVICE;
HEART TRANSPLANTATION;
HUMAN;
INSURANCE;
NATIONAL HEALTH INSURANCE;
OUTCOME ASSESSMENT;
QUALITY ADJUSTED LIFE YEAR;
SAFETY;
UNITED STATES;
BLUE CROSS;
BLUE SHIELD;
COST-BENEFIT ANALYSIS;
DEVICE APPROVAL;
EVIDENCE-BASED MEDICINE;
HEART FAILURE, CONGESTIVE;
HEART TRANSPLANTATION;
HEART-ASSIST DEVICES;
HUMANS;
INSURANCE COVERAGE;
OUTCOME ASSESSMENT (HEALTH CARE);
QUALITY-ADJUSTED LIFE YEARS;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84921704364
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (25)
|
|
References (0)
|